|
Real-time Estimate
Cboe BZX
20:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 28.26 USD | -0.25% |
|
+1.72% | +13.18% |
| 09-29 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 09-29 | Nurix Therapeutics to Receive $7 Million Pfizer Collaboration Milestone Payment | MT |
| Market Cap | 164B 144B 137B 124B 232B 15,708B 235B 1,640B 632B 8,021B 615B 601B 25,812B | P/E 2026 * |
18.1x | P/E 2027 * | 14x |
|---|---|---|---|---|---|
| Enterprise Value | 211B 186B 176B 160B 300B 20,264B 303B 2,115B 815B 10,348B 793B 776B 33,299B | EV / Sales 2026 * |
3.39x | EV / Sales 2027 * | 3.42x |
| Free-Float |
59.05% | Yield 2026 * |
5.99% | Yield 2027 * | 6.04% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PFE | Delayed | |
CBOE
| PFE | Real-time | |
|
Tradegate
| PFE | Real-time | |
|
Xetra
| PFE | Delayed | |
|
CBOE
| PFEs | Real-time | |
|
Boerse Muenchen
| PFE | Real-time | |
|
Borsa Italiana
| 1PFE | End-of-day quote | |
|
Mexican S.E.
| PFE * | End-of-day quote | |
|
Deutsche Boerse AG
| PFE | Delayed | |
|
London S.E.
| PFZ | Delayed | |
|
Bulgaria S.E.
| PFE | End-of-day quote | |
|
Wiener Boerse
| PFE | End-of-day quote | |
|
Kazakhstan S.E.
| PFE_KZ | End-of-day quote | |
|
Börse Stuttgart
| PFE | Delayed | |
|
Bolsa De Valores De Colombia
| PFECO | End-of-day quote | |
|
Swiss Exchange
| PFE | Delayed | |
|
Lima
| PFEUS | End-of-day quote | |
|
Santiago S.E.
| PFECL | End-of-day quote | |
|
Santiago S.E.
| PFE | End-of-day quote | |
|
CBOE
| PFZ | Real-time | |
|
Swiss Exchange
| PFE | Delayed |
Last Transcript: Pfizer Inc.
| 1 day | -0.25% | ||
| 1 week | +1.72% | ||
| Current month | +0.07% | ||
| 1 month | +1.87% | ||
| 3 months | +17.21% | ||
| 6 months | +3.89% | ||
| Current year | +13.18% |
| 1 week | 28.03 |  | 28.89 |
| 1 month | 27 | | 29.15 |
| Current year | 23 | | 29.15 |
| 1 year | 23 | | 29.15 |
| 3 years | 20.82 | | 34.59 |
| 5 years | 20.82 | | 61.4 |
| 10 years | 20.82 | | 61.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
Cecile Guegan
DFI | Director of Finance/CFO | 55 | 2026-08-15 |
Rady Johnson
CMP | Compliance Officer | 65 | 2013-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.25% | +1.72% | - | - | 164B | |
| -0.01% | +1.24% | +63.06% | +120.55% | 1,056B | |
| -1.61% | -0.60% | +47.32% | +71.79% | 655B | |
| -1.12% | -0.72% | +17.98% | +76.63% | 471B | |
| -1.72% | -4.06% | +36.39% | +39.47% | 342B | |
| -0.40% | +3.83% | +22.08% | +28.82% | 277B | |
| -0.51% | -1.93% | +12.09% | +11.94% | 257B | |
| +1.32% | +3.27% | +54.63% | +57.63% | 226B | |
| -0.61% | -0.91% | +34.33% | +101.87% | 189B | |
| -0.24% | -2.76% | -28.41% | -60.92% | 170B | |
| Average | -0.19% | +0.09% | +28.83% | +49.75% | 404.77B | |
| Weighted average by Cap. | -0.06% | +0.42% | +38.91% | +70.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.24B 54.92B 51.97B 47.13B 88.35B 5,972B 89.23B 623B 240B 3,050B 234B 229B 9,813B | 59.77B 52.74B 49.9B 45.26B 84.85B 5,735B 85.69B 599B 231B 2,929B 224B 220B 9,424B |
| Net income | 8.9B 7.85B 7.43B 6.74B 12.64B 854B 12.76B 89.15B 34.36B 436B 33.42B 32.69B 1,403B | 11.08B 9.78B 9.25B 8.39B 15.73B 1,063B 15.89B 111B 42.78B 543B 41.61B 40.7B 1,747B |
| Net Debt | 47.48B 41.9B 39.65B 35.96B 67.41B 4,556B 68.08B 476B 183B 2,327B 178B 174B 7,487B | 40.98B 36.17B 34.22B 31.03B 58.18B 3,932B 58.75B 410B 158B 2,008B 154B 151B 6,462B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | US$28.33 | -1.29% | 2,149 |
| 26-09-28 | US$28.70 | +1.31% | 394 |
| 26-09-25 | US$28.33 | -1.36% | 39 |
| 26-09-24 | US$28.72 | +2.90% | 2,546 |
| 26-09-23 | US$27.91 | +0.22% | 2,170 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PFE Stock
- PFE_KZ Stock
Select your edition
All financial news and data tailored to specific country editions
